Back to search

Article

EVA: a Foundation Model Advancing Translational Drug Development in Immuno-Inflammation

2025-05-07

Abstract excerpt

Drug development is a lengthy and high-risk process, with most investigational drug candidates failing in phase II randomized clinical trials (RCT) due to insufficient efficacy. It makes early prediction of trial outcomes crucial for reducing attrition and guiding strategic decisions, especially in immunology and inflammation (I&I) diseases. Herein, we present EVA, the first pre-trained foundation model in complex...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
621b86ce-d6c4-58c9-b271-b065c172a257
DOI
10.1101/2025.05.02.651839
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
EVA: a Foundation Model Advancing Translational Drug Development in Immuno-InflammationDOI 10.1101/2025.05.02.651839
Select a neighboring publication to make it the new centre.